UA89626U - Solid dosage form of sedative and hypnotic drug - Google Patents
Solid dosage form of sedative and hypnotic drugInfo
- Publication number
- UA89626U UA89626U UAU201314077U UAU201314077U UA89626U UA 89626 U UA89626 U UA 89626U UA U201314077 U UAU201314077 U UA U201314077U UA U201314077 U UAU201314077 U UA U201314077U UA 89626 U UA89626 U UA 89626U
- Authority
- UA
- Ukraine
- Prior art keywords
- sedative
- dosage form
- solid dosage
- hypnotic drug
- oil
- Prior art date
Links
- 239000003326 hypnotic agent Substances 0.000 title abstract 2
- 239000000932 sedative agent Substances 0.000 title abstract 2
- 230000001624 sedative effect Effects 0.000 title abstract 2
- 239000007909 solid dosage form Substances 0.000 title abstract 2
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 2
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 2
- UEBARDWJXBGYEJ-UHFFFAOYSA-N 2-bromo-3-methylbutanoic acid Chemical compound CC(C)C(Br)C(O)=O UEBARDWJXBGYEJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 125000004494 ethyl ester group Chemical group 0.000 abstract 1
- 239000007902 hard capsule Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
A solid dosage form of sedative and hypnotic drug in a form of the tablets or the hard capsules contains the ethyl ester of α-bromoisovaleric acid, mint oil, or the mixture of mint oil and hop oil, β-cyclodextrin, hydroxisin, and the structured water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201314077U UA89626U (en) | 2013-12-03 | 2013-12-03 | Solid dosage form of sedative and hypnotic drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201314077U UA89626U (en) | 2013-12-03 | 2013-12-03 | Solid dosage form of sedative and hypnotic drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA89626U true UA89626U (en) | 2014-04-25 |
Family
ID=52282065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201314077U UA89626U (en) | 2013-12-03 | 2013-12-03 | Solid dosage form of sedative and hypnotic drug |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA89626U (en) |
-
2013
- 2013-12-03 UA UAU201314077U patent/UA89626U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2014003306A1 (en) | Oral pharmaceutical preparation comprising a bruton tyrosine kinase inhibitor and crystalline form thereof. | |
| ECSP15013227A (en) | STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB | |
| CL2015002148A1 (en) | Pharmaceutical formulations resistant to improper handling | |
| IN2015DN03984A (en) | ||
| PL3003285T3 (en) | Solid pharmaceutical dosage form for release of at least two active pharmaceutical ingredients in the oral cavity | |
| MX2016003754A (en) | A stable pharmaceutical composition containing amlodipine and valsartan. | |
| EA201400737A1 (en) | DELIVERY SYSTEM ON THE BASIS OF A PELLET SET WITH IMMEDIATE release of an ACTIVE SUBSTANCE | |
| BR112016026667A2 (en) | orally disintegrating tablet for administration of avanafil, associated methods of manufacturing and use of a pdev inhibitor. | |
| MX2016006087A (en) | Rapidly disintegrating formulations and methods of use. | |
| UY34786A (en) | PROCEDURE FOR THE MANUFACTURE OF A PHARMACEUTICAL FORM INCLUDING NIFEDIPINO AND CANDESARTAN CILEXETILO | |
| MX2016015261A (en) | Allisartan isoproxil solid dispersion and pharmaceutical composition thereof. | |
| UY34931A (en) | ? COMPOSITE FORMULATION FOR ORAL ADMINISTRATION THAT INCLUDES METFORMIN AND ROSUVASTATIN ?. | |
| EA201200485A1 (en) | ORAL FALLING PHARMACEUTICAL DRUG FORM CONTAINING AIPIPRAZOL | |
| PH12014501840A1 (en) | Pharmaceutical formulation having improved stability | |
| UY31887A (en) | USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR USE IN THE PREVENTION OF CARDIOVERSION | |
| CL2016000397A1 (en) | Cancer treatment | |
| CL2014001581A1 (en) | Pharmaceutical combination comprising a) an antiepileptic selected from pregabalin or oxcarbazepine and b) vitamins selected from i) vitamin b12, ii) vitamin b1 and b12, with the exception of methylcobalamin and benfothiamine; pharmaceutical composition; and its use to treat or prevent moderate to severe pain; parts kit | |
| UA89626U (en) | Solid dosage form of sedative and hypnotic drug | |
| UA88462U (en) | Solid dosage form of drug with sedative and hypnotic effects | |
| EA201692426A1 (en) | COMBINATIONS OF ZALTOPROFENA AND MIORELAXANT | |
| NZ702849A (en) | Genotype- or phenotype-based drug formulation | |
| UA111358C2 (en) | Drug in form of tablets or hard capsules exhibiting sedative and hypnotic effects | |
| UA75723U (en) | medicinal product of spasmolytic and sedative action | |
| UA109702C2 (en) | SOLID MEDICINAL FORM OF SEDATIVE AND SODIOLOGICAL ACTION | |
| UA116011C2 (en) | Phenylephrine resinate particles and use thereof in pharmaceutical formulations |